Evidence map›Paper›PMID 41398321›Full record

ArticleNature communications2025

Structural basis for genome-wide site-specific DNA recognition by Nuclear Factor IA.

Ci Zhu, Ding Xiao, Zhipu Luo, Jie Zhang, Shuang Liu, Yueyu Wang, Xi Chen, Hejin Xiao, Xiaofeng Li, Juyu Tang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ci Zhu *State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Ding Xiao *National Clinical Research Center for Geriatric Disorders, XiangYa Hospital, Changsha, Hunan, China.ORCID http://orcid.org/0009-0009-9664-4815
Zhipu Luo *MOE Key Laboratory of Geriatric Diseases and Immunology, Institute of Molecular Enzymology, School of Life Sciences, Soochow University, Suzhou, China.ORCID http://orcid.org/0000-0003-0685-0754
Jie ZhangSchool of Life Sciences, Tsinghua University, Beijing, China.
Shuang LiuDepartment of Orthopedics, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yueyu WangState Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Xi ChenState Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Hejin XiaoSchool of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
Xiaofeng LiDepartment of Orthopedics, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Juyu TangNational Clinical Research Center for Geriatric Disorders, XiangYa Hospital, Changsha, Hunan, China.
Xianyang FangState Key Laboratory of RNA Innovation, Science and Engineering, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0001-9432-9736
Jie ShenDepartment of Orthopaedic Surgery, Washington University, St. Louis, MO, USA. shen.j@wustl.edu.ORCID http://orcid.org/0000-0003-4131-1211
He SongState Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. hesong@um.edu.mo.

Funding

Basic Research Program of Jiangsu Province BK20243030Universidade de Macau (University of Macau) SRG2023-00054-ICMS
6 · The paper itself

Abstract

Nuclear Factor IA, a member of the long-studied Nuclear Factor I family of DNA-binding proteins, plays pivotal roles in development and metabolism. Dysregulation or loss of Nuclear Factor IA is associated with severe neurological defects in humans and disruptions in fatty acid metabolism linked to conditions such as osteoarthritis. Despite extensive study, the DNA recognition mechanism of Nuclear Factor I family proteins remains unresolved. Previous studies have proposed that these proteins dimerize via their DNA-binding domains to bind TGGCA-containing dyad sequences. In this study, we demonstrate that both full-length Nuclear Factor IA and its isolated DNA-binding domain are monomeric in solution, challenging dimer models. Genome-wide ChIP-Seq analysis shows TGGCA half-sites are enriched among Nuclear Factor IA binding motifs. We determine Nuclear Factor IA's crystal and solution structures bound to half-site and dyad-symmetric DNA motifs, providing a structural basis for its monomeric DNA recognition. Furthermore, functional binding assays show that key residues in Nuclear Factor IA, which facilitate base-specific interactions, are critical for DNA sequence recognition and binding. These findings establish the DNA-binding mechanism of Nuclear Factor IA and provide a detailed molecular framework for understanding the functions of this classic transcription factor family.

Indexed as

DNADNA-Binding ProteinsNFI Transcription FactorsBinding SitesCrystallography, X-RayHumansModels, MolecularProtein BindingProtein DomainsProtein MultimerizationDNADNA-Binding ProteinsNFI Transcription Factors

Identifiers

PMID41398321
PMCPMC12830966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.